Selin Nalbantoglu
Staff Reporter
selin.nalbantoglu@yale.edu
Selin Nalbantoglu covers breakthrough research for SciTech. She is a first-year in Saybrook College.
Author Archive
SELIN NALBANTOGLU
RNA Vaccines, ultrasound therapies and more: Yale researchers stay active through the pandemic

Despite the effects of the COVID-19 pandemic, Yale researchers have continued to push the frontiers of science, publishing hundreds of scientific articles and developing new […]

May 22, 2022

SELIN NALBANTOGLU
Yale penicillin allergy testing initiative clears most pregnant women of reported allergy

Two YNHH physicians have developed an initiative to test and identify pregnant women who report penicillin allergies in order to verify or clear the reported allergy.

April 27, 2022

SELIN NALBANTOGLU
Specific cancer characteristics may determine patient outcomes, Yale analysis finds

Yale researchers analyzed a data set of more than 10,000 cancer patients and identified certain biomarkers associated with higher rates of patient mortality.

April 26, 2022

SELIN NALBANTOGLU
New ultrasound treatment for Type II diabetes developed by Yale-GE Collaboration

Yale researchers in Raimund Herzog’s lab are working alongside GE Research to develop an ultrasound treatment for Type II diabetes.

April 12, 2022

SELIN NALBANTOGLU
“Supercharged” T-cells attack cancer cells more effectively, Yale study shows

Yale researchers have identified specific genes within T-cells that can be amplified to increase a T-cell’s ability to identify and kill cancer cells.

March 31, 2022

SELIN NALBANTOGLU
Novel imaging technique allows doctors to track synaptic activity in patients with Alzheimer’s disease

By radioactively labeling a protein involved in neuron communication, Yale researchers are able to track and image synaptic activity in patients.

March 17, 2022

SELIN NALBANTOGLU
Novel Yale-developed stem cell therapy helps prevent hip replacements

A Yale surgeon is developing a new surgical therapy that uses a patient’s own stem cells to repair dying bone before the hip collapses.

March 16, 2022

SELIN NALBANTOGLU
Yale researchers study ketamine as a potential treatment for depression in patients with Parkinson’s disease

A clinical study examining the effects of ketamine as a treatment for depression in patients with Parkinson’s disease is currently underway at Yale New Haven Hospital.

March 4, 2022

SELIN NALBANTOGLU
Yale researchers develop model system for the study of Alzheimer’s

Researchers in the department of genetics at the Yale School of Medicine have developed a technique that allows them to construct 3D brain organoids to better study Alzheimer’s disease.

February 15, 2022

SELIN NALBANTOGLU
New nasal vaccine could provide protection against COVID-19 infection, Yale study suggests

A new intranasal vaccine developed by the Iwasaki Lab at Yale shows promise in preventing COVID-19 infection in mice.

February 11, 2022

SELIN NALBANTOGLU
Reptiles and viruses: New E&EB faculty lead research

Brandon Ogbunu Ph.D. ’10 and Martha Muñoz head some of the newest laboratories within the Ecology and Evolutionary Biology department.

February 2, 2022